This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 10166267

PUBLISHED SUBJECT

61/8001/2023 - Autorização de Utilização Excecional do Medicamento

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
- - Exeltis Healthcare
Awardee
Duxpharma Unipessoal Lda. · Tax ID 510803679
Awardee
Roche Farmacêutica Química, Lda. · Tax ID 500233810
Awardee
medac Sucursal em Portugal · Tax ID 980369959
Awardee
Bausch & Lomb · Tax ID 980218764
Awardee
XPHARMA, LDA · Tax ID 516248138
Awardee
FARMA MONDO IBERIA SUCURSAL · Tax ID 980693063
Awardee
Inovemed - Produtos Farmacêuticos, Lda · Tax ID 513038876

Values and timeline

Contract price
€125,037.75
Procedure base price
€125,037.75
Total effective price
Not reported on Portal BASE
Publication date
28 July 2023
Award date
12 January 2023
Signing date
12 January 2023
Performance period
366 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Monofator
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 24.º, n.º 4 do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
6627959

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts